Loading...
Genetic Vaccines to Potentiate the Effective CD103(+)DC-mediated Cross-priming of Anti-tumor Immunity
The development of effective cancer vaccines remains an urgent, but as yet unmet, clinical need. This deficiency is in part due to an incomplete understanding of how to best invoke dendritic cells (DC) that are crucial for the induction of tumor-specific CD8(+)T cells capable of mediating durable pr...
Saved in:
| Published in: | J Immunol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4458448/ https://ncbi.nlm.nih.gov/pubmed/25972487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1500089 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|